Mühl A, Alessandrì MG, Bianchi MC, Tosetti M, Fornai F and Cioni G. Arginine:Glycine Amidinotransferase Deficiency: the third inborn error of creatine metabolism in man. Am J Hum Genet, 69, 1127-1233, 2001.

Bibliografia

1. Arias-Dimas A, Vilaseca MA, Artuch R, Ribes A, Campistol J Diagnóstico y tratamiento de los síndromes de deficiencia de creatina cerebral. Rev Neurol 43 (5), 302-308, 2006.

2. Item BC, Stöckler-Ipsiroglu S, Stromberger C,

Mühl A, Alessandrì MG, Bianchi MC, Tosetti M, Fornai F and Cioni G. Arginine:Glycine Amidinotransferase Deficiency: the third inborn error of creatine metabolism in man. Am J Hum Genet, 69, 1127-1233, 2001.

3. Stöckler S, Holzbach U, Hanefeld F, Marquardt I, Helms G, Requart M, Hanicke W, Frahm J. Creatine deficiency in the brain: a new, treatable inborn error of metabolism. Pediatric Research, 36, 409-413, 1994.

4. Figura von K, Hanefeld F, Isbrandt D, Stöckler-Ipsiroglu S.

Guanidinoacetate methyltransferase deficiency. The metabolic and

molecular basis of inherited disease. (Scriver CR, Beaudet AL, Sly WS,

Valle D., Eds), New York: McGraw Hill, 8

Ed. pag. 1897-1908, 2000.

5. Verhoeven NM, Salomons GJ, Jakobs C Laboratory diagnosis of defects of creatine biosynthesis and transport Clinica Chimica Acta 361, 1-9, 2005.

6. Battini R, Leuzzi V, Carducci Ca, Tosetti M, Bianchi MC, Item C, Stockler S, Cioni G. Creatine depletion in a new case with AGAT deficiency:clinical and genetic study in a large pedigree. Mol Gen Metab 77, 326-331, 2002.

7. Battini R, Alessandrì MG, Leuzzi V, Moro F, Tosetti M, Bianchi MC, Cioni G. Arginine: glicine amidinotransferase (AGAT) deficency ina newborn: early treatment can prevent phenotypic expression of the disease. J Pediatr 148, 828-830, 2006.

8. Item CB, Mercimek-Mahmutoglu S, Battini R, Edlinger-Horvat C, Stromberger C, Bodamer O, Mühl A, Vilaseca MA, Korall H, and Stöckler-Ipsiroglu S. Chatacterization of seven novel mutation in seven patient with GAMT deficiency. Human Mutation 709, 2004.

9. Schulze A, Hess T, Wevers R, Mayatepek E, Bachert P, Marescau B, Knopp M, De Deyn PP, Bremer HJ, Rating D. Creatine deficiency syndrome caused by guanidinoacetate methyltransferase deficiency:

diagnostictools or a new inborn error of metabolism. J Pediatr 131, 626- 631, 1997.

10. Ganesan V, Johnson A, Connelly A, Eckhardt S, Surtees AH.

Guanidinoacetate methyltransferase deficiency: new clinical features.

Pediatr Neurol 17, 155-157, 1997.

11. Leuzzi V, Bianchi MC, Tosetti M, Carducci Cl, Cerquiglini A, Cioni G,

Antonozzi I. Brain creatine depletion: guanidinoacetate

methyltransferasedeficiency (improving with creatine supplementation).

Neurology 55, 1407-1409, 2000.

12. Stockler S, Marescau B, De Deyn PP, Trijbels JMF, Hanefeld F.

Guanidino compounds in guanidinoacetate methyltransferase deficiency, a newinborn error of creatine synthesis. Metabolism 46, 1189-1193, 1997.

13. Schulze A, Mayatepek E, Rating D. Improved treatment of guanidinoacetato methyltransferase (GAMT) deficiency. J Inher Metab Dis 23(1), 211, 2000.

14. Sykut-Cegielska J, Gradowska W, Mercimek-Mahmutoglu S, Stöckler- Ipsiroglu S. Biochemical and clinical characteristics of creatine deficiency syndromes. Acta Biochimica Polonica 51 (4), 875-882, 2004.

15. Dal Pozzo G. Compendio di Risonanza Magnetica cranio e rachide.

Ed.UTET. Diagnostica per immagini, Cap. 1-3 pag. 3-54; Cap. 8 pag. 79- 205, 2001.

16. Danielsen ER, Ross B. Magnetic resonance spectroscopy diagnosis of neurological diseases. Marcel Dekker AG ed. New York (USA): Marcel Dekker Inc. 1999.

17. Ross B, Michaelis T. Clinical applications of magnetic resonance spectroscopy. Magn Reson Q., 10, 191-247, 1994.

18. Rosenberg EH, Almeida LS, Kleefstra T, deGrauw RS, Yntema HG, Bahi N, Moraine C, Ropers H, Fryne J, deGrauw TJ, Jakobs C, SalomonsGS.

High prevalence of SLC6A8 deficiency in X-linked mental retardation.

Am J Hum Genet 75, 97-105, 2004.

19. Clark AJ, Rosenberg EH, Almeida LS, Wood TC, Jakobs C, Stevenson RE, Schwartz CE, Salomons GS. X-linked creatine trasporter (SLC6A8) mutations in about 1% of males with mental retardation of unknown etiology. Hum Genet 119, 604-610, 2006.

20. Pyne-Geithman GJ, deGraw TJ, Cecil KM, Chuck G, Lyons MA, IshidaY, Clark JF. Presence of normal creatine in the muscle of a patien twith a mutation in the creatine transporter: A case study. Molecular and cellular Biochemistry 262, 35-39, 2004.

21. Struys EA, Jansen EE, Ten Brink Hj, Verhoeven NM, van der Knaap MS, Jakobs C. An accurate stable isotope dilution gas chromatographic-mass spectrometric approach to the diagnosis of guanidinoacetate methyltransferase deficiency. J. Pharm Biomed Anal 18, 659-665,1998.

22. Carducci Cl, Birarelli M, Leuzzi V, Carducci C, Battini R, Cioni G, Antonozzi I. Guanidinoacetate and creatine plus creatinina assessment in physiologic fluids: an effective tool for the biochemical diagnosis of arginine:glycine amidinotransferase and guanidinoacetate methyltransferase deficiencies. Clin Chem 48(10), 1772-1778, 2002.

23. Salomons GJ, van Dooren SJM, Verhoeven NM, Cecil KM, Ball WS, DeGraw TJ, Jacobs C. X-linked creatine transporter (SLC6A8 gene)defect: a new creatine deficiency syndrome. Am J Hum Genet 68, 1497-1500, 2001.

24. Cecil KM, Salomons GS, Ball WS, Wong B, Chuck G, Nanda M,

JacobsC, deGraw TJ. Irreversible Brain Creatine Deficiency with

Elevated Serum and Urine Creatine: A Creatine Transporter Defect. Ann

Neurol 49, 401-404, 2001.

25. Bizzi A, Bugiani M, Salomons GS, Hunneman DH, Moroni I, Estienne M, Danesi U, Jakobs C, Uziel G. X-linked creatine deficiency syndrome:a novel mutation in creatine transporter gene SLC6A8. Ann Neurol 52(2), 227-231, 2002.

26. Mancini GMS, Catsman-Berrevoets CE, deCoo IFM, Aarsen F, Huijmans JGM, Duran M, van der Knapp MS, Jakobs C, Salomons GC. A novel splice-site mutation in SLC6A8 causes creatine transporter defectand X- linked mental retardation in a Dutch family. Am J Med Genet 123(3), 288-295, 2005.

27. Schiaffino MC, Bellini C, Costabello L, Caruso U, Jakobs C, Salomons GS, Bonioli E. X-linked creatine transporter deficiency. Clinical description of a patient with a novel SLC6A8 gene mutation.

Neurogenetics. 6(3), 165-168, 2005.

28. Poo-Arguelles P, Arias A, Vilaseca MA, Ribes A, Artuch R, Sans-Fito A, Moreno A, Jakobs C, Salomons GS. X-linked creatine transporter deficiency in two patients with severe mental retardation and autism. J Inherit Metab Dis. 29, 220-223, 2006.

29. Anselm IM, Alkuraya FS, Salomons GS, Jakobs C, Fulton AB, Mazumdar M, Rivkin M, Frye R, Young Poussaint T, Marsden D. X- linked creatine transporter defect: A report on two unrelated boys with a severe clinical phenotype. J Inherit Metab Dis. 29, 214-219, 2006.

30. Betz H, Gomeza J, Armsen W, et al., Glycine transporter: essential

regulators of synaptic transmission. Biochem Soc Trans, 34, 55-58, 2006.

31. O’Kane RL, Viňa JR, Simpson I, Zaragoza R, Mokashi A, Hawkins RA.

Cationic amino acid transport across the blood-brain barrier is mediated by system y+. Am J Physiol Endocrinol Metab 291, 412-419, 2006.

32. Alessandrì MG, Celati L, Battini R, Casarano M, Cioni G. Gas chromatography/mass spectrometry assay for arginine:glycine- amidinotransferase deficiency. Analitical Biochemistry 343, 356-358, 2005.

33. Lowry OH. Protein measurement withthe Folin phenol reagent. J Biol Chem 193, 265-275, 1951.

34. Alessandrì MG, Celati L Battini R, Baldinotti F, Item C, Leuzzi V, Cioni G. HPLC for guanidinoacetate methyltransferase. Analytical Biochemistry 331,189-191, 2004.

35. Wyss M, Kaddurah-Daouk R. Creatine and creatinine metabolism Physiol Rew 80, 1107-1213, 2000

36. Leiter RG. International Performance Scales (LIPS). Wood Dale (IL):

Stoelting Co, 1997. Italian translation: Firenze: OS Orgabnizzazioni Speciali, 2002

37. Fenson L, Dale PS, Reznick JS, Thal D, Bates E, Hartung JP, Pethick S,

Reilly JS. Mac Arthur Communicative Development Inventories: user’s

guide and technical manual. San Diego: Singular Publishing Group,

1993. Italian Adaptation: Caselli MC, Casadio P, Il primo vocabolario del

bambino: guida all’uso del questionario Mac Arthur per la valtazione

della comunicazione e del linguaggio nei primi anni di vita. Milano,

Franco Angeli, 1995.

38. Axia G. TPL – Test del primo linguaggio. Firenze: OS Organizzazioni Speciali 1994.

39. Dunn LM. Peabody Picture Vocabulary Test – PPVT 3th Edition Minneapolis (MN): American Guidance Service, 1997. Italian Adaptation: Stella G, Pizzoli C, Tressoldi P. PPVT – revised. Torino:

Omega Edition, 2000.

40. Chilosi AM, Cipriani P. TCGB: Test di comprensione grammaticale per bembini. Tirrenia (Pisa): Edizioni del Cerro, 1996.

41. Sparrow SS, Balla DA, Cicchetti DV. Vineland Adaptative Behavior Scales. Minneapolis (MN): American Guidance Service, 1984. Italian Adaptation: Balboni G, Petrabbissi L. Firenze: OS Organizzazioni Speciali, 2003.

42. Braissant O, Henry H, Loup M, Eilers B, Bachmann C. Endogenous synthesis and transport of creatine in the rat brain: an in situ hybridization study. Mol Brain Res 86,193-201, 2001.

43. Ohtsuki S, Tachikawa M, Takanaga H, Shimizu H, Watanabe M, Hosoya K, Terasaki T The blood-brain barrier creatine transporter is a major pathway for supplying creatine to the brain. J Cereb Blood Flow Metab 22, 1327-1335, 2002.

44. Walker JB. Creatine: biosynthesis, regulation, and function. Adv Emzymol 50, 177-242, 1979.

45. Schulze A, Hoffmann GF, Bachert P, Kirsch S, Salomon GS, Verhoeven

NM, Mayatepek E. Presymptomatic treatment of neonatal

Guanidinoacetate methyltransferase deficiency. Neurology 67, 719-721, 2006.

46. Leonard JV, Morris AA. Urea cycle disorders. Semin Neonatol 7, 27-35, 2002

47. Dringen R, Verleysdonk S, Hamprecht B, Willker W, Leibfritz D, Brand A. Metabolisme of Glycine in primary astroglial cells: synthesis of creatine, serine and glutathione. J Neurochem 70, 835-840, 1998.

48. Lunardi G, Parodi A, Perasso L, Pohvozcheva AV, Scarrone S, Adriano

E, Florio T, Gandolfo C, Cupello A, Burov SV, Balestrino M. The

creatine transporter mediates the uptake of creatine by brain tissue, but

not the uptake of creatine-derived compuonds. Neuroscience 142, 991-

997, 2006.